These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9491011)

  • 1. Screening for tuberculosis in jail and clinic follow-up after release.
    Tulsky JP; White MC; Dawson C; Hoynes TM; Goldenson J; Schecter G
    Am J Public Health; 1998 Feb; 88(2):223-6. PubMed ID: 9491011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail.
    White MC; Tulsky JP; Goldenson J; Portillo CJ; Kawamura M; Menendez E
    Arch Intern Med; 2002 May; 162(9):1044-50. PubMed ID: 11996616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of TB in inmates with latent TB infection: 5-year follow-up.
    White MC; Tulsky JP; Menendez E; Goldenson J; Kawamura LM
    Am J Prev Med; 2005 Nov; 29(4):295-301. PubMed ID: 16242592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail.
    White MC; Tulsky JP; Reilly P; McIntosh HW; Hoynes TM; Goldenson J
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):506-12. PubMed ID: 9626609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis screening in the federal prison system: an opportunity to treat and prevent tuberculosis in foreign-born populations.
    Saunders DL; Olive DM; Wallace SB; Lacy D; Leyba R; Kendig NE
    Public Health Rep; 2001; 116(3):210-8. PubMed ID: 12034910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directly observed isoniazid preventive therapy for released jail inmates.
    Nolan CM; Roll L; Goldberg SV; Elarth AM
    Am J Respir Crit Care Med; 1997 Feb; 155(2):583-6. PubMed ID: 9032198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of tuberculosis screening and management practices of large jail systems.
    Reichard AA; Lobato MN; Roberts CA; Bazerman LB; Hammett TM
    Public Health Rep; 2003; 118(6):500-7. PubMed ID: 14563907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for effective education in a jail setting: the Tuberculosis Prevention Project.
    White MC; Duong TM; Cruz ES; Rodas A; McCall C; Menéndez E; Carmody ER; Tulsky JP
    Health Promot Pract; 2003 Oct; 4(4):422-9. PubMed ID: 14611027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates.
    Bock NN; Rogers T; Tapia JR; Herron GD; DeVoe B; Geiter LJ
    Chest; 2001 Mar; 119(3):833-7. PubMed ID: 11243965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in a correctional facility.
    Pelletier AR; DiFerdinando GT; Greenberg AJ; Sosin DM; Jones WD; Bloch AB; Woodley CL
    Arch Intern Med; 1993 Dec; 153(23):2692-5. PubMed ID: 8250665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of Tuberculosis services in Indian Prisons.
    Prasad BM; Thapa B; Chadha SS; Das A; Babu ER; Mohanty S; Pandurangan S; Tonsing J
    Int J Infect Dis; 2017 Mar; 56():117-121. PubMed ID: 28179148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving tuberculosis therapy completion after jail: translation of research to practice.
    White MC; Tulsky JP; Menendez E; Arai S; Goldenson J; Kawamura LM
    Health Educ Res; 2005 Apr; 20(2):163-74. PubMed ID: 15314035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor continuity of care for TB diagnosis and treatment in Zambian Prisons: a situation analysis.
    Hatwiinda S; Topp SM; Siyambango M; Harris JB; Maggard KR; Chileshe C; Kapata N; Reid SE; Henostroza G
    Trop Med Int Health; 2018 Feb; 23(2):243-250. PubMed ID: 29230918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of syphilis detected through a jail screening program. A potential public health measure to address the syphilis epidemic.
    Heimberger TS; Chang HG; Birkhead GS; DiFerdinando GD; Greenberg AJ; Gunn R; Morse DL
    Arch Intern Med; 1993 Aug; 153(15):1799-804. PubMed ID: 8333816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance to treatment of latent tuberculosis infection in a region of Israel.
    Bibi H; Weiler-Ravell D; Shoseyov D; Feigin I; Arbelli Y; Chemtob D
    Isr Med Assoc J; 2002 Jan; 4(1):13-6. PubMed ID: 11802301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis prevalence in an urban jail: 1994 and 1998.
    White MC; Tulsky JP; Portillo CJ; Menendez E; Cruz E; Goldenson J
    Int J Tuberc Lung Dis; 2001 May; 5(5):400-4. PubMed ID: 11336269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience.
    Swaminathan S; Chandrasekaran P
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):289-92. PubMed ID: 24455973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study.
    Okwara FN; Oyore JP; Were FN; Gwer S
    BMC Infect Dis; 2017 Sep; 17(1):623. PubMed ID: 28915796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.